Engler Renata J M, Brede Emily, Villines Todd, Vernalis Marina N
is a Professor of Medicine and Pediatrics and is an Adjunct Assistant Professor of Medicine at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. is a Professor of Medicine in the Cardiology Division at the University of Virginia Health System in Charlottesville, Virginia. is a Protocol Developer; Renata Engler is a Consultant of Cardiovascular Immunology, Diagnostic Laboratory Immunology, Allergy-Immunizations, Integrative Medicine and Research; and Marina Vernalis is Medical Director, Integrative Cardiac Health Project, Cardiology; all at the Henry M. Jackson Foundation, in Bethesda.
Fed Pract. 2019 Nov;36(Suppl 7):S19-S31.
Newly recognized as a clinical diagnosis, Lp(a) elevation is a major contributor to cardiovascular disease risk should be considered for patients with advanced premature atherosclerosis on imaging or a family history of premature cardiovascular disease, particularly when there are few traditional risk factors.
Lp(a)升高最近被确认为一种临床诊断,它是心血管疾病风险的主要促成因素,对于影像学显示有晚期早发性动脉粥样硬化或有早发性心血管疾病家族史的患者应予以考虑,尤其是在传统风险因素较少的情况下。